| Filed On | Filing |
|---|---|
| 16 Nov 2026 | SCHEDULE 13G/A |
| 09 Nov 2026 |
Form 4: Inglis John C, Director
Bought 127.5309 shares ($10K) |
| 05 Nov 2026 | 144 |
| 04 Nov 2026 | 10-Q |
| 03 Nov 2026 |
8-K: Results of Operations and Financial Condition; Other Events
■General Insurance net premiums written (NPW) of $6.7 billion, an increase of 7% year-over-year on a reported basis and 8% on a constant dollar basis*, driven by 7%* growth in Global Commercial and 9%* growth in Global Personal |
| 22 Oct 2026 | 13F-HR |
| 21 Oct 2026 |
Form 4: Walsh Keith, EVP and CFO
Gave up 688 shares to cover exercise price or tax ($56.2K) |
| 16 Oct 2026 |
Form 4: Dandridge Edward Lee, EVP, Chief Marketing & Comms
Received 2,813 shares by exercise or conversion · Gave up 1,437 shares to cover exercise price or tax ($116K) |
| 16 Oct 2026 | 144 |
| 13 Oct 2026 |
Form 3: Hussain Mohammad, EVP, Chief Risk Officer
Holds 37,372 shares of Common Stock |
| 01 Oct 2026 |
Form 4: Wittman Vanessa Ames, Director
Granted 76 Deferred Stock Unit |
| 01 Oct 2026 |
Form 4: Perez Juan R., Director
Granted 34 Deferred Stock Unit |
| 01 Oct 2026 |
Form 4: Stoddard Thomas D, Director
Granted 15 Deferred Stock Unit |
| 01 Oct 2026 |
Form 4: Murphy Diana M, Director
Granted 76 Deferred Stock Unit |
| 01 Oct 2026 |
Form 4: Leimkuhler Courtney, Director
Granted 39 Deferred Stock Unit |
| 01 Oct 2026 |
Form 4: Inglis John C, Director
Granted 50 Deferred Stock Unit |
| 01 Oct 2026 |
Form 4: Cole James Jr., Director
Granted 126 Deferred Stock Unit |
| 01 Oct 2026 |
Form 4: Rice John G, Director
Granted 1,403 Deferred Stock Unit |
| 01 Oct 2026 |
Form 4: Porrino Peter R, Director
Granted 884 Deferred Stock Unit |
| 01 Oct 2026 |
Form 4: Mills Linda A, Director
Granted 817 Deferred Stock Unit |
Loading...